See you at:
Aptamers2014 (24-25 March 2014, Oxford, UK)
RNAi2014, (25-27 March 2014, Oxford, UK)
NGS 2014, (31 March-03 April 2014, Oxford, UK)
Oxford academic RNAi conferences offer best scientific programme in Europe, attracting a global participation of leading scientists from academia and industry, postdoctoral researchers and students. These conferences provide an excellent opportunity to establish new collaborative links with academic and industrial colleagues and to find a PhD or a postdoctoral position.
Professor Kostas Kostarelos, University of London, UK
Carbon nanotube-mediated siRNA delivery
Professor Dr Achim Aigner, Philipps-University, Germany
Polyplex-mediated in vivo delivery of miRNA-145 or miRNA-33a for therapy of colon carcinoma in xenograft mouse models
Dr Mirko Ludwig, University of Jena, Germany
Cell-specific gene silencing in vivo using peptide-blocked siRNAs
Professor Andrew Miller, King’s College London, UK
Delivering on RNAi therapeutics, molecular imaging and theranostics; what do we think that we know?
Professor Yaping Tian, Chinese PLA General Hospital, China
Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies
Dr Samira Lakhal-Littleton, University of Oxford, UK
Exosome-mediated RNAi delivery for neurological disease
Dr Nikos Hontzeas, Sigma-Aldrich, USA
MICRORNA TARGET VALIDATION: MISSION® 3’UTR Lenti GoClones and human microRNA mimics
Dr Mark Behlke, IDT DNA, USA
Novel chemistries for anti-miRNA oligonucleotides
Professor Nagy A Habib, Imperial College London, UK
Oligonucleotides for cell reprogramming: Characterisation of short RNAs that activate KLF4 expression
Professor Sir David Baulcombe (Keynote Speaker), University of Cambridge, UK
RNA silencing, virus resistance, mobile signals and genome interactions
Dr Steve Brown, RNAi Facility, University of Shefield, UK
Genome-wide RNAi screens using High Content Microscopy
Technology Workshop by Molecular Devices
Technology Workshop by Sigma-Aldrich
Professor Dr Johannes Grillari, University of Natural Resources and Applied Life Sciences, Austria
MicroRNA-31 is secreted by senescent endothelial cells and inhibits osteogenic differentiation of mesenchymal stem cells
Dr David Horn, London School of Tropical Medicine and Hygiene, London, UK
RNAi libraries for high throughput phenotyping and drug resistance screening in African trypanosomes
Professor Adrian Harris (Keynote Speaker), CRUK, Oxford, UK
Hypoxia induced miRNAs: Mechanisms of effect, prognostic factors and therapeutic targets
Dr Sam Griffiths-Jones, University of Manchester, UK
Integration of microRNA annotation and deep-sequencing data
Dr Patrick Lu, Siranomics, USA
TGFβ1/COX-2 siRNA inhibitors for novel anti-scar therapeutics
Professor John J O’Leary, Trinity College Dublin, Ireland
Molecular targeting of HPV oncogenes and the role of miRNA-21 in the cancer cascade
Professor Andrew Hamilton, University of Glasgow, UK
MicroRNAs in erythrocytes
Professor Dr Georg Sczakiel, University of Lubeck, Germany
Limitations for RNAi: intracellular release of siRNA and cell stress
Dr Roger Adami, Marina Biotech, Inc, USA
A novel amino acid-based delivery platform for therapeutic applications inbladder cancer and hepatocellular carcinoma
Dr Natalia Botchkareva, University of Bradford, UK
MicroRNA-21 mediates the effects of the BMP signalling pathway in keratinocytes